Skip to content

The Policy Vault

Methodology Why Contact

Coverage / Highmark / Xalkori Crizotinib

Xalkori Crizotinib — Highmark

3 indications indexed for this drug.

Metastatic Nsclc
View coverage criteria
Relapsed Or Refractory Systemic Anaplastic Large Cell Lympho
View coverage criteria
Unresectable Recurrent Or Refractory Inflammatory Myofibrobl
View coverage criteria

The Policy Vault

Structured prior authorization and step-therapy criteria for commercial health plans. Built by pharmacists for healthcare professionals.

Disclaimer: Educational use only. Coverage varies by employer group and formulary. Always verify with the plan.

Product

Coverage Directory
Why Policy Vault
Methodology

Company

Contact
Press
Support

© 2025 The Policy Vault. Data sourced from official health plan documents.